Carol Addy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Carol addy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Carol Addy Today - Breaking & Trending Today

(GNFT) - Why Genfit Shares Soared 150% Today


Share:
Genfit SA (NASDAQ: GNFT) shares shot up 150% in the after-hours trading today.
What Happened: The France-based late-stage biopharmaceutical company said in the after-hours Tuesday that positive results from the Phase 2 trial evaluating elafibranor in patients with Primary Biliary Cholangitis have been published.
“These data support the potential for elafibranor as novel treatment in PBC and confirm the rationale of evaluating our compound in this disease in a pivotal Phase 3 trial,” said Carol Addy,  the chief medical officer at Genfit. 
Why It Matters: Elafibranor was given the Breakthrough Therapy designation by the United States Food and Drug Administration as well as Orphan Drug designation by the FDA and the European Medicines Agency. ....

United States , Carol Addy , European Medicines Agency , Drug Administration , Primary Biliary Cholangitis , Breakthrough Therapy , United States Food , Orphan Drug , European Medicines , ஒன்றுபட்டது மாநிலங்களில் , திருப்புமுனை சிகிச்சை , ஒன்றுபட்டது மாநிலங்களில் உணவு , ஆர்ஃபந் மருந்து , ஐரோப்பிய மருந்துகள் ,